Edesa Biotech, Inc. (EDSA)

Edesa Biotech Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2012	FY 2011
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Aug 31, 2012	Aug 31, 2011
Cash & Equivalents	10	10.79	1.04	1.01	4.24
Cash & Short-Term Investments	10	10.79	1.04	1.01	4.24
Cash Growth	-28.01%	940.39%	2.53%	-76.12%	-
Accounts Receivable	0.22	0.64	0.27	0.02	0.04
Other Current Assets	0.2	0.08	0.37	0.03	0.04
Total Current Assets	10.42	11.51	1.68	1.06	4.31
Net Property, Plant & Equipment	-	-	0.02	0.34	0.35
Other Intangible Assets	1.93	1.98	2.08	0.15	0.18
Other Long-Term Assets	0.04	0.04	0.04	0.02	0.02
Total Assets	12.38	13.53	3.81	1.56	4.86
Accounts Payable	2.19	1.08	1.81	0.44	0.16
Current Portion of Leases	-	-	0.02	-	-
Unearned Revenue	-	-	-	0.13	-
Total Current Liabilities	2.19	1.08	1.83	0.57	0.16
Other Long-Term Liabilities	-	-	-	0.13	1.56
Total Long-Term Liabilities	-	-	-	0.13	1.56
Total Liabilities	2.19	1.08	1.83	0.7	1.72
Preferred Stock	8.37	9.26	-	-	-
Common Stock	58.93	54.52	47.24	9.63	7.35
Additional Paid-in Capital	15.53	14.75	13.58	1.68	1.01
Accumulated Other Comprehensive Income	-0.19	-0.17	-0.24	-	-
Retained Earnings	-72.45	-65.91	-58.59	-10.45	-5.23
Shareholders' Equity	10.2	12.45	1.98	0.86	3.13
Total Liabilities & Equity	12.38	13.53	3.81	1.56	4.86
Total Debt	-	0	0.02	0	0
Net Cash (Debt)	10	10.79	1.02	1.01	4.24
Net Cash Growth	-7.31%	960.71%	0.56%	-76.12%	-
Net Cash Per Share	1.31	1.90	0.32	67.95	327.05
Book Value	10.2	12.45	1.98	0.86	3.13
Book Value Per Share	1.33	2.19	0.62	57.92	241.74
Tangible Book Value	8.27	10.47	-0.1	0.72	2.95
Tangible Book Value Per Share	1.08	1.85	-0.03	48.05	228.02

Updated May 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q